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Objectives. The event risk of patients with coronary heart disease may be estimated by a 
large-scale prognostic database in a Japanese population. The aim of this study was to create a 
Heart Risk Table for predicting the major cardiac event rate. 
Methods. Using the J-ACCESS database created by a prognostic investigation involving 117 
hospitals and >4000 patients in Japan, multivariate logistic regression analysis was performed. 
The major event rate over a 3-year period that included cardiac death, non-fatal myocardial 
infarction and severe heart failure requiring hospitalization was predicted by the logistic 
regression equation. The algorithm for calculating the event rate was simplified for creating 
tables. 
Results. Two tables were created to calculate cardiac risk by age, perfusion score category and 
ejection fraction with and without a presence of diabetes. A relative risk table comparing 
age-matched control subjects was also made. When the simplified tables were compared with the 
results from original logistic regression analysis, both risk values and relative risks agreed well 
(p<0.0001 for both).  
Conclusion. The Heart Risk Table was created for patients suspected of having ischemic heart 
disease and who underwent myocardial perfusion gated single-photon emission computed 
tomography. The validity of risk assessment using a J-ACCESS database should be validated in a 
future study. 
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Introduction 
Prediction of cardiac events has been considered important for management of patients with 
ischemic heart disease.1, 2 In the era of multi-modality cardiac imaging including cardiac 
echocardiography, x-ray computed tomography and magnetic resonance imaging, nuclear 
methods have been validated well for estimating cardiac risks of future events. In spite of the 
well-known role of nuclear cardiology in this field, there has been no definite evidence for a 
Japanese population based on large-scale multi-center cohort studies. A prognostic study using 
stress-rest myocardial perfusion single-photon emission computed tomography (SPECT) has thus 
been performed in Japan to create a Japanese database since 2001.3 The study design, reliability 
of the gated SPECT methodology, normal values and major cardiac event rates in a Japanese 
population have been published.4-6 The prospective study involved 117 hospitals, and >4600 
subjects were registered and followed up for 3 years. The study enabled patients to stratify risks 
according to the predicted rate of future events. Namely, low-risk patients were indicated for less 
invasive means or primary preventions, whereas high-risk patients were indicated for coronary 
revascularization or more invasive approaches.7 
 The purpose of this study was to create practical tables to estimate cardiac event risks 
based on a multivariate analysis. To make the practical tables from the statistics, a simplified 
model for calculating event rates was required. We compared the created table and the results of 
the original regression formula.  
 
Materials and methods 
J-ACCESS investigation 
The subjects and method have been described elsewhere.3, 6 Briefly, a total of 4031 
patients were analyzed after excluding early revascularization within 60 days of the SPECT study. 
The inclusion criteria included ≥20 years of age who were undergoing stress and rest ECG-gated 
SPECT due to suspected or known ischemic heart diseases. Patients with onset of myocardial 
infarction or unstable angina pectoris within 3 months, valvular heart disease, idiopathic 
cardiomyopathy, severe arrhythmia, heart failure with class III or higher New York Heart 
Association classification, and severe liver or renal disorders were excluded. During the 3-year 
follow-up, major cardiac events were defined as cardiac death, non-fatal myocardial infarction 
and severe heart failure requiring hospitalization.  
 
SPECT data analysis 
A myocardial perfusion study was performed using 99mTc-tetrofosmin using a standard 
stress-rest protocol. The SPECT images were divided into 17 or 20 segments, and visual 
perfusion for 99mTc-tetrofosmin uptake in individual segments was scored as follows: 0, normal; 1, 
mildly reduced; 2, moderately reduced; 3, severely reduced and 4, absent.8 The scores from the 
20-segment and 17-segment models were converted using the ratio of 17/20.8 Summed stress 
(SSS) and rest (SRS) scores were calculated based on the stress and rest findings. The summed 
Nakajima, et al. Heart Risk Table   - 3 - 
  
difference score (SDS) was defined as the difference between SSS and SRS. The severity of 
myocardial perfusion defects was defined with four grades of categories (O, I, II and III) using 
summed scores; namely, normal (score 0-3) and mildly reduced (score 4-8), moderately reduced 
(score 9-13) or severely reduced (score ≥14) in the 20-segment model, respectively.9, 10 Gated 
SPECT was quantitatively analyzed by QGS software (Cedars Sinai Medical Center, CA, USA).11 
 
Multivariate analysis 
 In-the J-ACCESS study, major cardiac events developed in 175 patients (4.3%/3 years), 
which comprised cardiac death, nonfatal myocardial infarction and severe heart failure.6 
Univariate analysis demonstrated significant variables of age, body mass index, diabetes mellitus, 
hypertension and history of revascularization and myocardial infarction. Multivariate analysis 
showed selected final variables of age, diabetes, summed stress score and end-systolic volume 
(ESV) or ejection fraction (EF). Thus, multivariate logistic regression analysis was applied in this 
study to estimate the event rate. 
 
Tables for cardiac risk 
 Since ESV depended on the patient height and weight, we used EF instead of ESV to 
simplify the table. Then, the predictors included continuous variables of EF and age. EF (0-100%) 
was classified into ten classes. Age was also classified into each ten-year-old class from 40 to 90 
years old; namely 40-49, 50-59 years old, and so on. The presence of diabetes was used as 0 or 1. 
SSS was classified into four categories as described above, since SSS had an ordinary scale. 
In the Heart Risk View, relative risk (unit: folds) was defined as the calculated risk 
divided by the age-matched normal values in non-diabetic subjects. Since the normal EF value of 
EF was influenced by factors of age and sex, the EF of control patients was determined 
accordingly in the Heart Risk View.5, 6, 12 In this Heart Risk Table, relative risk was similarly 
calculated, but the control EF was fixed to normal values of 65% for both sexes. 
 
Clinical validation of the Heart Risk Table 
 The risk values calculated by the equation from original multi-variate logistic analysis 
were compared with those obtained from values from the Heart Risk Table. A total of 31 
consecutive patients with stress-rest SPECT were analyzed by both Heart Risk View and Heart 
Risk Tables. The average age was 68?11 years old (27 males and 4 females). Diabetes was 
associated with 16 patients. The 17-segment-based SSS ranged from 0 to 28. The SSS categories 
were O (SSS 0-2, n=7), I (SSS 3-7, n=10), II (SSS 8-11, n=8) and III (>12, n=6). The calculated 
risk vales were classified into low (0 to 3%), intermediate (>3 to 9%), high (>9 to 15%) and very 
high (>15%) for three years. 
 
Statistics 
? Multivariate logistic analysis was performed as indicated above. Mean and standard deviations 
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(SD) were calculated for each parameter. The relationship between the risk value and the relative 
risk was calculated by linear regression analysis. Contingency table analysis was performed to 
compare risk severity groups, and the likelihood ratio and Pearson's chi-square were calculated. A 
p value < 0.05 was considered significant. 
 
Results 
Logistic regression analysis 
 The multivariate regression model determined by diabetes (0-1), age, SSS category (0-3) 
and EF was determined using a logit function as follows: 
? logit (p) = -4.8125 + 0.8858×(diabetes:0, 1) + 0.0558(age) + 0.1941×(SSS category:0-3) 
-0.0475×(EF) 
p (%/3 years)? = 1 / (1+e-logit (p)) ×100 
Based on this formula, risk and relative risk values were tabulated with respect to ten-year age 
classes and 10% EF classes. Figures 1A and 1B show cardiac risks for patients without and with 
diabetes mellitus. If the patient's age and the presence of diabetes were given, corresponding risk 
(%) and relative risk (folds) were found from the crossover point of the EF class and age class.  
 
Example of risk estimation 
Figure 2 shows an example of a 64-year old male patient with inferior hypoperfusion. 
The summed stress score of the inferior and septal wall was 9, and it was classified into moderate 
severity without significantly induced ischemia. The major cardiac event rate estimated in this 
case was 2.9%/3 years, which was 1.6 fold higher than that of the age-matched control subjects. 
Risk values determined by Heart Risk Table was 2.5%/3 years which was 1.8 folds of the 
controls.  
 
Comparison of Heart Risk Table with logistic regression analysis 
The estimated cardiac event risk and relative risk are compared (Figure 3). A good 
correlation between the Heart Risk View and simplified Heart Risk Table was observed. When 
the severity of risk was classified into four severity groups, complete agreement was observed in 
25 of 31 patients (81%), and all patients were within one grade of difference (Table 1) 
?  
Discussion 
 Heart Risk Table, which calculates the three-year major event rate, was created based on 
a J-ACCESS prognostic investigation. The correlation of risk values calculated by Heart Risk 
Table and by logistic regression analysis was good. A prognostic chart using a simplified look-up 
table was the first application in the field of nuclear medicine, and may be applicable to patients 
suspected of having coronary heart diseases. 
 
Event rate in the J-ACCESS study 
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The J-ACCESS investigation was first evidence made in a Japanese population who had 
undergone myocardial perfusion SPECT. When hard events, defined as cardiac death and 
non-fatal infarction, were the endpoints, cardiac death (n = 57, 1.4%/3 years) and non-fatal 
myocardial infarction (n = 39, 1.0%/3 years) occurred in 96 patients (2.4%/3 years) during the 
3-year follow-up period. When severe heart failure was included as an endpoint, major cardiac 
events developed in 175 patients (4.3%/3 years), which comprised cardiac death (n = 45,  1.1%/3 
years), non-fatal myocardial infarction (n = 37, 1.0%/3 years) and severe heart failure (n = 93, 
2.3%/3 years). Patients with normal and severely abnormal SSS had low (2.3%/3 years) and high 
(9.2%/3 years) rates of major cardiac events, respectively. Hachamovitch et al. showed that over a 
mean follow up of 642 days in 5183 patients, 277 hard events (5.3%) occurred, including 3.0% 
cardiac death rate, 2.3% myocardial infarction rate.9 Petix et al. showed that during follow-up 
(median 13 months) of 333 patients, 17 cardiac deaths (5.1%) and 13 nonfatal acute myocardial 
infarctions (3.9%) occurred.13 Although the study setting might differ among studies, the event 
rate was generally lower in Japan compared with those of Western studies.6, 9, 10, 13, 14 The annual 
hard event rate in normal myocardial perfusion SPECT was found to be low (0.63%) in the 
subanalysis.15 The importance of diabetes mellitus has been emphasized in a Japanese population, 
which has been also demonstrated in Western studies.14, 16, 17 
 
Multivariate analysis for this study 
The statistical analysis for predicting events was performed with the Cox proportional 
hazard model in the first summary,18 while the present study was based on the multivariate 
logistic regression model. The merit of the logistic regression model was that the risk values were 
directly estimated by the regression model, which might be intuitionally understood. A similar 
approach using a prognostic score for prediction of cardiac mortality risk after adenosine stress 
myocardial perfusion scintigraphy has been reported.19  
The logistic regression analysis using ESV instead of EF created the equation of  
logit p= -8.9333 + 0.9159×(diabetes:0, 1) + 0.0635×(age) + 0.225×(SSS categroy:0-3) + 
0.0182×(ESV)  
to calculate logit(p). Although the equations were also available in the Heart Risk View, 6, 12 we 
used only EF in this Table. Since the ESV was influenced by the physique of patients, we needed 
simplification for generating the table. 
 
Importance of predicting cardiac events 
 Predicting cardiac mortality risk or major event risk can provide valuable information for 
management of patients suspected of having ischemic heart disease. Hachamovitch et al 
demonstrated that revascularization in comparison to medical therapy had greater survival benefit in 
patients with moderate to large amounts of inducible ischemia.7 According to their results, a patient 
diagnosed with no or mild ischemia could be indicated for medication, whereas a patient having 
moderate to severe myocardial ischemia could be indicated for more aggressive treatment including 
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coronary intervention and coronary bypass surgery. The extent of the perfusion abnormality was the 
single most important prognostic predictor, even when coronary angiography was performed.20 The 
principal notion that myocardial perfusion abnormality or ischemia was strongly correlated with 
event rate has been validated even in recent studies. To estimate cardiac event risk, the 
recommended guidelines of blood pressure, total cholesterol, and low-density-lipoprotein 
cholesterol to predict coronary heart disease have been published from American Heart Association 
and the American College of Cardiology.21 In addition, a simple coronary disease prediction 
algorithm was developed using categorical variables, which allows physicians to predict cardiac 
risk in patients without overt coronary artery disease. In Japan, NIPPON DATA80 has been 
summarized using variables of sex, age, smoking, blood glucose level, blood pressure, total 
cholesterol, and other factors. The original charts based on the data provided risk for coronary heart 
disease, stroke, and all cardiovascular death risk among the general Japanese population. The 
present study also aimed at similar approaches using a myocardial perfusion study, although the 
number of variables was still limited. 
 Patients who underwent coronary revascularization within 60 days of the SPECT study were 
excluded from the study group. In clinical settings, those with moderate or severe stress-induced 
ischemia will be treated by coronary revascularization after the SPECT study. This sort of selection 
bias could not be avoided in the prognostic cohort study. However, the estimation of event risks 
before revascularization based on the prognostic database is meaningful for patient management.  
 
Notations for using Heart Risk Table 
 The table contains the characteristics of the J-ACCESS database. Selection biases are the 
same as those of the original J-ACCESS investigation. Although the patients were registered 
consecutively in 117 hospitals, relatively low risk patients for cardiac disease might have been 
included. However, this inclusion implied that the database reflected ordinary nuclear cardiology 
practice in Japan. Caution should be exercised for the application of Heart Risk Table, since the 
number of patients <40 years old are few, and baseline cardiac diseases such as cardiomyopathy 
and severe heart failure as shown in the Method section were excluded. It has been generally 
accepted that the cardiac event rate is less than 1%, when myocardial perfusion SPECT was 
normal.15, 22 However, radionuclide distribution throughout the myocardium, increased tracer lung 
uptake, transient ventricular dilatation after stress and balanced perfusion reduction in multi-vessel 
disease should also be considered to estimate patient disease severity and prognosis, which are not 
included in this table. Insufficient exercise level could also underestimate the ischemia. Moreover, 
we used only predictors defined by multivariate analysis. The occurrence of soft events may include 
history of revascularization, hypertension and dyslipidemia. The diagnosis of diabetes mellitus was 
made clinically in each institute, and the relationship of the severity of diabetes and event risks 
could not be analyzed in this study. The importance of diabetes will be clarified by the subsequent 
J-ACCESS 2 study, which focused specifically on diabetes mellitus.23  
 However, even considering these limitations, this Heart Risk Table does not contradict 
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previously published reports or guidelines. The idea for risk estimation should be taken into account 
for patient management for ischemic heart diseases. A further follow-up study would be valuable 




1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines 
for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College 
of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC 
Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). 
Circulation 2003;108:1404-18. 
2. Tamaki N. Guidelines for Clinical Use of Cardiac Nuclear Medicine (JCS 2005). Circulation  Journal 
2005;69 Suppl.  IV:1125-202. 
3. Kusuoka H, Nishimura S, Yamashina A, Nakajima K, Nishimura T. Surveillance study for creating the 
national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: 
J-ACCESS study design. Ann Nucl Med 2006;20:195-202. 
4. Nakajima K, Nishimura T. Inter-institution preference-based variability of ejection fraction and volumes 
using quantitative gated SPECT with 99mTc-tetrofosmin: a multicentre study involving 106 hospitals. Eur J 
Nucl Med Mol Imaging 2006;33:127-33. 
5. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Normal limits of ejection fraction and 
volumes determined by gated SPECT in clinically normal patients without cardiac events: a study based on 
the J-ACCESS database. Eur J Nucl Med Mol Imaging 2007;34:1088-96. 
6. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification 
among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS 
study. Eur J Nucl Med Mol Imaging 2007 
7. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival 
benefit associated with revascularization compared with medical therapy in patients with no prior coronary 
artery disease undergoing stress myocardial perfusion single photon emission computed tomography. 
Circulation 2003;107:2900-7. 
8. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. Prognostic validation of 
a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl 
Cardiol 2004;11:414-23. 
9. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of 
myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: 
differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43. 
10. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of 
post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon 
emission computed tomography. Circulation 1999;100:1035-42. 
11. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of 
Nakajima, et al. Heart Risk Table   - 8 - 
  
ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-47. 
12. Nishimura T. Software using J-ACCESS clinical database: Heart Risk View (User Manual) Version 1 [in 
Japanese], Nihon Medi Physics, Tokyo, Japan. 2007  
13. Petix NR, Sestini S, Coppola A, Marcucci G, Nassi F, Taiti A, et al. Prognostic value of combined perfusion 
and function by stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging in patients 
with suspected or known coronary artery disease. Am J Cardiol 2005;95:1351-7. 
14. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion 
single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on 
incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-33. 
15. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T. Prognostic value of normal stress myocardial 
perfusion imaging in Japanese population. Circ J 2008;72:611-7. 
16. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects 
with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 
1998;339:229-34. 
17. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial 
ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004;27:1954-61. 
18. Nishimura T, Nakajima K, Tsukamoto K. Estimation of cardiac event rate by myocardial SPECT based on 
Japanese EBM: development of Heart Risk View software [in Japanese]. Eizo Joho Medical 2008;40:430-5    
19. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of 
cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 
2005;45:722-9. 
20. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental 
prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in 
coronary artery disease. J Am Coll Cardiol 1993;22:665-70. 
21. Grundy SM, Pasternak R, Greenland P, Smith S, Jr., Fuster V. Assessment of cardiovascular risk by use of 
multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart 
Association and the American College of Cardiology. Circulation 1999;100:1481-92. 
22. Bateman T. Clinical relevance of a normal myocardial perfusion scintigraphic study. J Nucl Cardiol 
1998;4:172-3. 
23. Kusuoka H, Yamasaki Y, Izumi T, Kashiwagi A, Kawamori R, Shimamoto K, et al. Surveillance study for 
creating the national clinical database relating to ECG-gated myocardial perfusion SPECT of asymptomatic 





Nakajima, et al. Heart Risk Table   - 9 - 
  
 




Nakajima, et al. Heart Risk Table   - 11 - 
  
Figure 1 Cardiac event rate for three years estimated by age, EF and SSS category. Charts A and 
B indicate risk values for patients without and with diabetes mellitus. Color-coding from light to 




Figure 2 An example of Heart Risk View results. Risk values determined by Heart Risk Table in 
this patient was 2.5%/3 years, which was 1.8 fold higher than that of the controls. 
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Figure 3 Comparison of risk values (%/3 years) and relative risk to control patients (folds) 
between Heart Risk Table and Heart Risk View.  
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Table 1. Comparison of grade of risks estimated by Heart Risk View and Heart Risk Table 
?  Heart Risk Table  ?  ?  ?  
?  low intermediate high very high total 
Heart Risk View     
 low 10 2 0 0 12 
 intermediate 1 10 1 0 12 
 high 0 1 2 0 3 
 very high 0 0 1 3 4 
total 11 13 4 3 31 
likelihood ratio?Chi square 43.1, p<0.0001 
Pearson: Chi square 50.3, p<0.0001 
Risks were defined as low risk (0-3%), intermediate risk (>3 to 9%), high risk (>9% to 15%) 
and very high risk (>15%) for three years. 
 
